You have no items in your shopping cart.
RecombinantGRO-γ/CXCL3,Human(CHO-expressed) [orb1494731]> 98% as analyzed by SDS-PAGE.
9 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg- RecombinantGranzymeB,Mouse [orb1494734]
> 98% as analyzed by SDS-PAGE.
32 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg - RecombinantGCP-2/CXCL6,Human [orb1494743]
> 98% as analyzed by SDS-PAGE.
9 kDa, observed by reducing SDS-PAGE.
CHO
5 μg, 25 μg - RecombinantFractalkine/CX3CL1,Human [orb1494744]
> 95% as analyzed by SDS-PAGE.
50-75 kDa, observed by reducing SDS-PAGE.
CHO
25 μg, 5 μg, 1 mg - RecombinantFGF-16,Human [orb1494749]
> 95% as analyzed by SDS-PAGE and HPLC.
23 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg - RecombinantI‑TAC/CXCL11,Human(HEK293-expressed) [orb1494634]
> 98% as analyzed by SDS-PAGE.
8.3 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg - RecombinantIP-10/CRG-2/CXCL10,Rat [orb1494635]
> 98% as analyzed by SDS-PAGE.
8.7 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg, 1 mg - RecombinantIL-2Rα,His,Human [orb1494639]
> 95% as analyzed by SDS-PAGE and HPLC.
42 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantFractalkine/CX3CL1,Rat [orb1494649]
> 98% as analyzed by SDS-PAGE.
70-90 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg - RecombinantFasR,Human [orb1494650]
> 95% as analyzed by SDS-PAGE.
17~29 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg